Sharing Patient-Controlled Real-World Data Through the Application of the Theory of Commons: Action Research Case Study.

eHealth knowledge commons learning networks patient and family centered care

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
19 01 2021
Historique:
received: 12 11 2019
accepted: 17 12 2020
revised: 15 06 2020
entrez: 19 1 2021
pubmed: 20 1 2021
medline: 1 5 2021
Statut: epublish

Résumé

Technological advances have radically changed the opportunities for individuals with chronic conditions to practice self-care and to coproduce health care and research. Digital technologies enable patients to perform tasks traditionally carried out by health care professionals in a more convenient way, at lower costs, and without compromising quality. Patients may also share real-world data with other stakeholders to promote individual and population health. However, there is a need for legal frameworks that enable patient privacy and control in such sharing of real-world data. We believe that this need could be met by the conceptualization of patient-controlled real-world data as knowledge commons, which is a resource shared by a group of people. This study aimed to propose a conceptual model that describes how patient-controlled real-world data can be shared effectively in chronic care management, in a way that supports individual and population health, while respecting personal data privacy and control. An action research approach was used to develop a solution to enable patients, in a self-determined way, to share patient-controlled data to other settings. We chose the context of cystic fibrosis (CF) care in Sweden, where coproduction between patients, their families, and health care professionals is critical in the introduction of new drugs. The first author, who is a lawyer and parent of children with CF, was a driver in the change process. All coauthors collaborated in the analysis. We collected primary and secondary data reflecting changes during the time period from 2012 to 2020, and performed a qualitative content analysis guided by the knowledge commons framework. Through a series of changes, a national system for enabling patients to share patient-controlled real-world data to different stakeholders in CF care was implemented. The case analysis resulted in a conceptual model consisting of the following three knowledge commons arenas that contributed to patient-controlled real-world data collection, use, and sharing: (1) patient world arena involving the private sphere of patients and families; (2) clinical microsystem arena involving the professional sphere at frontline health care clinics; and (3) round table arena involving multiple stakeholders from different settings. Based on the specification of property rights, as presented in our model, the patient can keep control over personal health information and may grant use rights to other stakeholders. Health information exchanges for sharing patient-controlled real-world data are pivotal to enable patients, health care professionals, health care funders, researchers, authorities, and the industry to coproduce high-quality care and to introduce and follow-up novel health technologies. Our model proposes how technical and legal structures that protect the integrity and self-determination of patients can be implemented, which may be applicable in other chronic care settings as well.

Sections du résumé

BACKGROUND
Technological advances have radically changed the opportunities for individuals with chronic conditions to practice self-care and to coproduce health care and research. Digital technologies enable patients to perform tasks traditionally carried out by health care professionals in a more convenient way, at lower costs, and without compromising quality. Patients may also share real-world data with other stakeholders to promote individual and population health. However, there is a need for legal frameworks that enable patient privacy and control in such sharing of real-world data. We believe that this need could be met by the conceptualization of patient-controlled real-world data as knowledge commons, which is a resource shared by a group of people.
OBJECTIVE
This study aimed to propose a conceptual model that describes how patient-controlled real-world data can be shared effectively in chronic care management, in a way that supports individual and population health, while respecting personal data privacy and control.
METHODS
An action research approach was used to develop a solution to enable patients, in a self-determined way, to share patient-controlled data to other settings. We chose the context of cystic fibrosis (CF) care in Sweden, where coproduction between patients, their families, and health care professionals is critical in the introduction of new drugs. The first author, who is a lawyer and parent of children with CF, was a driver in the change process. All coauthors collaborated in the analysis. We collected primary and secondary data reflecting changes during the time period from 2012 to 2020, and performed a qualitative content analysis guided by the knowledge commons framework.
RESULTS
Through a series of changes, a national system for enabling patients to share patient-controlled real-world data to different stakeholders in CF care was implemented. The case analysis resulted in a conceptual model consisting of the following three knowledge commons arenas that contributed to patient-controlled real-world data collection, use, and sharing: (1) patient world arena involving the private sphere of patients and families; (2) clinical microsystem arena involving the professional sphere at frontline health care clinics; and (3) round table arena involving multiple stakeholders from different settings. Based on the specification of property rights, as presented in our model, the patient can keep control over personal health information and may grant use rights to other stakeholders.
CONCLUSIONS
Health information exchanges for sharing patient-controlled real-world data are pivotal to enable patients, health care professionals, health care funders, researchers, authorities, and the industry to coproduce high-quality care and to introduce and follow-up novel health technologies. Our model proposes how technical and legal structures that protect the integrity and self-determination of patients can be implemented, which may be applicable in other chronic care settings as well.

Identifiants

pubmed: 33464212
pii: v23i1e16842
doi: 10.2196/16842
pmc: PMC7854041
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16842

Informations de copyright

©Andreas Hager, Staffan Lindblad, Mats Brommels, Stina Salomonsson, Carolina Wannheden. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 19.01.2021.

Références

Harv Bus Rev. 2000 Sep-Oct;78(5):102-12, 199
pubmed: 11143147
BMJ. 2016 Jul 01;354:i3319
pubmed: 27370543
JMIR Mhealth Uhealth. 2019 Feb 22;7(2):e10401
pubmed: 30794202
Patient Educ Couns. 2012 Aug;88(2):170-6
pubmed: 22360841
BMJ Open. 2018 Sep 8;8(9):e023113
pubmed: 30196269
QJM. 2017 Mar 1;110(3):125-129
pubmed: 27803364
BMJ. 2009 Feb 17;338:b49
pubmed: 19223339
JMIR Hum Factors. 2018 Feb 22;5(1):e8
pubmed: 29472173
JMIR Form Res. 2019 Mar 14;3(1):e9858
pubmed: 30869643
BMJ. 2000 Jan 15;320(7228):178-81
pubmed: 10634744
Jt Comm J Qual Improv. 2002 Sep;28(9):472-93
pubmed: 12216343
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Lancet. 2016 Nov 19;388(10059):2519-2531
pubmed: 27140670
Pediatrics. 2013 Jun;131 Suppl 4:S219-23
pubmed: 23729764
N Engl J Med. 2012 Mar 1;366(9):780-1
pubmed: 22375967
Int J Qual Health Care. 2013 Apr;25(2):118-24
pubmed: 23360809
Health Aff (Millwood). 2014 Jul;33(7):1163-70
pubmed: 25006142
J Cyst Fibros. 2019 Jan;18(1):94-101
pubmed: 30146268
Qual Manag Health Care. 2009 Oct-Dec;18(4):247-56
pubmed: 19851232
BMJ Qual Saf. 2016 Jul;25(7):509-17
pubmed: 26376674
JMIR Pediatr Parent. 2018 Dec 10;1(2):e11080
pubmed: 31518297
Med Ref Serv Q. 2016;35(1):94-100
pubmed: 26794199
Eur J Cardiovasc Nurs. 2011 Dec;10(4):248-51
pubmed: 21764386
J Cyst Fibros. 2014 May;13 Suppl 1:S23-42
pubmed: 24856775
BMJ Qual Saf. 2014 Apr;23 Suppl 1:i90-4
pubmed: 24608555
J Med Internet Res. 2019 Nov 27;21(11):e14537
pubmed: 31774410

Auteurs

Andreas Hager (A)

Upstream Dream AB, Bromma, Sweden.

Staffan Lindblad (S)

Upstream Dream AB, Bromma, Sweden.

Mats Brommels (M)

Medical Management Centre, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden.

Stina Salomonsson (S)

Center for Observational and Real World Evidence, Merck Sharp and Dohme, Stockholm, Sweden.

Carolina Wannheden (C)

Medical Management Centre, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH